Linguistic markers of neurodegenerative diseases, ANA Congress
Talk on the latest advances in linguistic markers of brain health. For more information, please click here.
TELL has become a member of the AABC!
TELL, our speech testing app, has been incorporated into the Alzheimer’s Association Business Consortium. We are excited to team up with notable stakeholders to develop scalable solutions for patients worldwide. For more information on the AABC, click here.
Artificial intelligence and medicine: five free apps to detect possible diseases and take care of your health (in Spanish)
The same engine that drives the wheel of artificial intelligence is beginning to control clinical tools capable of analyzing a patient’s condition and providing immediate diagnoses with a high degree of certainty. In this article, five free applications to consult medical symptoms remotely and take care of your health. You can read the full article, […]
Groundbreaking speech assessment study in Peru
TELL is the tool of choice for groundbreaking speech assessment study in Peru. The project entitled «Natural language-based markers for the discrimination of neurodegenerative diseases», funded by CONCYTEC, Peru, seek to validate natural language markers capable of differentiating the most frequent neurodegenerative disorders in older adults in Arequipa. Principal Investigator: Marcio Soto Añari Coinvestigators: José […]
Speech and language biomarkers, at AAIC Satellite Symposium
Dr. Adolfo García introduced our automated speech and language markers framework at the AAIC Satellite Symposium in Mexico City.
Brain Awareness Week in Argentina
TELL was proud sponsor of Brain Week, the Argentine chapter of Brain Awareness Week.
TELL: A novel speech testing app for insights on brain health
By 2050, over 150 million people will be diagnosed neurodegenerative disorders, including Alzheimer’s disease, Parkinson’s disease, and frontotemporal dementia. This scenario has spurred a quest for objective, affordable, scalable markers to improve early detection and symptom monitoring. Prominent among these efforts is automated speech and language analysis (ASLA), with several papers demonstrating its potential to […]
From the lab to an app, for NeuroTechX BA (in Spanish)
Dr. Adolfo Garcia gave a talk on the transition from basic science to an app and the emergence of TELL for the Argentine chapter of NeuroTechX. El Dr. Adolfo García dio una charla sobre la transición de ciencia básica a una app y el surgimiento de TELL para el capítulo argentino de NeuroTechX.
TELL, an app to evaluate speech in neurodegenerative diseases (in Spanish)
Dr. Adolfo García was invited to Radio LU19 to talk about TELL, the app to evaluate speech in neurodegenerative diseases he developed with his team. El Dr. Adolfo García fue invitado a Radio LU19 para hablar sobre TELL, la app para evaluar el habla en enfermedades neurodegenerativas que desarrolló junto a su equipo.
The TELL app, for CNN Radio Argentina (in Spanish)
Dr. Adolfo García was invited to CNN Radio to talk about TELL, the app to evaluate speech in neurodegenerative diseases he developed with his team. El Dr. Adolfo García fue invitado a CNN Radio para hablar sobre TELL, la app para evaluar el habla en enfermedades neurodegenerativas que desarrolló junto a su equipo.